IFRA urges inclusion of potency for assessing endocrine disruptors
IFRA supports the inclusion of potency, exposure, severity and irreversibility as criteria to help identify endocrine disrupters of concern.
Rue de la Croix d’Or 3
1204 Geneva
Switzerland